Idiopathic and systemic sclerosis-associated pulmonary arterial hypertension: a comparison of demographic, hemodynamic, and MRI characteristics and outcomes

S Ramjug, N Hussain, J Hurdman, C Billings… - Chest, 2017 - Elsevier
Background Previous studies have identified survival in systemic sclerosis (SSc)-associated
pulmonary arterial hypertension (SSc-PAH) as being worse than in idiopathic pulmonary …

Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and management

…, A Charalampopoulos, S Ramjug… - Pulmonary …, 2016 - journals.sagepub.com
The most common cause of pulmonary hypertension (PH) due to left heart disease (LHD) was
previously rheumatic mitral valve disease. However, with the disappearance of rheumatic …

Pulmonary arterial hypertension associated with congenital heart disease: comparison of clinical and anatomic–pathophysiologic classification

S Ramjug, N Hussain, J Hurdman, C Billings… - The Journal of Heart and …, 2016 - Elsevier
Background Between 5% and 10% of patients with congenital heart disease (CHD) develop
pulmonary arterial hypertension (PAH-CHD). Patients can be classified using either a …

Prolonged time between donor brain death and organ retrieval results in an increased risk of mortality in cardiac transplant recipients

S Ramjug, N Hussain, N Yonan - Interactive cardiovascular and …, 2011 - academic.oup.com
In cardiac transplantation longer ischemic times relate to poorer outcomes. However, brain
death also promotes donor organ injury. The aim of this study was to ascertain if there was an …

[PDF][PDF] Isolated anterior cruciate ligament deficiency, knee scores and function.

S Ramjug, S Ghosh, G Walley, N Maffulli - Acta Orthopædica …, 2008 - academia.edu
The aim of this study was to ascertain whether there was a correlation between commonly
used scoring scales used for follow-up study of management of knee problems and whether …

Long‐term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease‐associated pulmonary arterial hypertension

S Ramjug, N Hussain, J Hurdman, CA Elliot… - …, 2017 - Wiley Online Library
Background and objective There are few published data on the efficacy of iv iloprost in
pulmonary arterial hypertension ( PAH ). We present long‐term outcomes in PAH patients …

ERS International Congress 2021: highlights from the pulmonary vascular diseases assembly

M Lichtblau, L Piccari, S Ramjug, A Bokan… - ERJ open …, 2022 - Eur Respiratory Soc
This article aims to summarise the latest research presented at the virtual 2021 European
Respiratory Society (ERS) International Congress in the field of pulmonary vascular disease. …

Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists

…, DG Kiely, JD Pauling, S Ramjug… - … of Scleroderma and …, 2024 - journals.sagepub.com
Objectives: The objectives were to explore rheumatologists’ current clinical screening
practices of pulmonary arterial hypertension in patients with systemic sclerosis in the United …

ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly

S Ramjug, J Weatherald, S Sahay, J Khoury… - ERJ Open …, 2020 - Eur Respiratory Soc
The 2019 European Respiratory Society (ERS) International Congress, held in Madrid, Spain,
had exciting sessions regarding the field of pulmonary vascular disease. The symposia …

[HTML][HTML] Update in the diagnosis and management of acute pulmonary embolism for the non-respiratory physician

S Ramjug, G Phillips - Clinical Medicine, 2021 - ncbi.nlm.nih.gov
An increasingly common scenario on the acute medical take is that of ‘possible pulmonary
embolism’. The aim of this article is to update the reader about the available clinical decision …